Localization of the malignant hyperthermia susceptibility locus to human chromosome 19ql2–13.2

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Nature

• Publication date

  1990-02-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/343562A0PMID 2379741
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The halothane sensitivity locus and its linkage relationships.

  2009cited by this paper
• Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia

  1990cited by this paper
• Recombination events that locate myotonic dystrophy distal to APOC2 on 19q.

  1989cited by this paper
• A multipoint linkage map around the locus for myotonic dystrophy on chromosome 19.

  1989cited by this paper
• A reordering of human chromosome 19 long-arm DNA markers and identification of markers flanking the myotonic dystrophy locus.

  1989cited by this paper
• Definition of subchromosomal intervals around the myotonic dystrophy gene region at 19q.

  1989cited by this paper
• A primary map of ten DNA markers and two serological markers for human chromosome 19.

  1988cited by this paper
• Abnormal sarcoplasmic reticulum ryanodine receptor in malignant hyperthermia.

  1988cited by this paper
• Dantrolene—An Update

  1987cited by this paper
• Regional mapping of human chromosome 19: organization of genes for plasma lipid transport (APOC1, -C2, and -E and LDLR) and the genes C3, PEPD, and GPI.

  1986cited by this paper
• European Malignant Hyperpyrexia Group.

  1984cited by this paper
• Strategies for multilocus linkage analysis in humans.

  1984cited by this paper
• In Vitro Contracture Tests for Susceptibility to Malignant Hyperthermia

  1983cited by this paper
• H blood types in pigs as predictors of stress susceptibility.

  1976cited by this paper
• Book Review: Recent Advances in Anæsthesia and Analgesia

  1973cited by this paper
• Malignant hyperthermia: A statistical review

  1970cited by this paper
• Changes underlying Halothane-induced Malignant Hyperpyrexia in Landrace Pigs

  1970cited by this paper
• Malignant hyperthermia during anesthesia and surgery.

  1970cited by this paper
• Hyperpyrexia During Anaesthesia

  1968cited by this paper
• Unusual reaction to suxamethonium chloride.

  1966cited by this paper

• European Malignant Hyperthermia Group 2025 guidelines for the investigation of malignant hyperthermia susceptibility.

  2026cites this paper
• Emerging Trends in Malignant Hyperthermia; Uncommon Yet Increasingly Seen in the Indian Subcontinent

  2025cites this paper
• Allele Frequencies and Genotypes for the Ryanodine Receptor 1 Variant Causing Malignant Hyperthermia and Fatal Rhabdomyolysis With Hyperthermia in Horses

  2025cites this paper
• Disorders of Muscle Mass and Tone.

  2025cites this paper
• Genetic Testing for Malignant Hyperthermia Susceptibility—Threading the Needle in the Haystack

  2025cites this paper
• Hipertermia maligna

  2023cites this paper
• What is malignant hyperthermia susceptibility?

  2023cites this paper
• The 100 most cited articles in malignant hyperthermia

  2023cites this paper
• Resolving the neural mechanism of core object recognition in space and time: A computational approach.

  2022cites this paper
• Malignant Hyperthermia: A Killer If Ignored.

  2022cites this paper
• A case of giant dental calculus in a patient with centronuclear myopathy.

  2022cites this paper
• Dietary Caffeine Synergizes Adverse Peripheral and Central Responses to Anesthesia in Malignant Hyperthermia Susceptible Mice

  2020cites this paper
• Malignant Hyperthermia Update.

  2020cites this paper
• Permeabilised skeletal muscle reveals mitochondrial deficiency in malignant hyperthermia‐susceptible individuals

  2019cites this paper
• Maligne Hyperthermie: Diagnostik konkret

  2019cites this paper
• Bayesian modeling to predict malignant hyperthermia susceptibility and pathogenicity of RYR1, CACNA1S and STAC3 variants.

  2019cites this paper
• Genetics without genes? The centrality of genetic markers in livestock genetics and genomics

  2019cites this paper
• PRE-PROOF – ACCEPTED FOR PUBLICATION IN HISTORY AND PHILOSOPHY OF THE LIFE SCIENCES 1 Genetics without genes? The centrality of genetic markers in livestock genetics and genomics

  2019cites this paper
• The current status of malignant hyperthermia.

  2019cites this paper
• Genetic epidemiology of malignant hyperthermia in the UK

  2018cites this paper
• A genetic mystery in malignant hyperthermia 'solved'?

  2018cites this paper
• Inhalative Analgosedierung auf der Intensivstation

  2018cites this paper
• The emerging role of calmodulin regulation of RyR2 in controlling heart rhythm, the progression of heart failure and the antiarrhythmic action of dantrolene

  2017cites this paper
• Round Table on Malignant Hyperthermia in Physically Active Populations: Meeting Proceedings.

  2017cites this paper
• Pharmakogenetik in Anästhesie und Intensivmedizin

  2016cites this paper
• Sequencing of Genes Involved in the Movement of Calcium across Human Skeletal Muscle Sarcoplasmic Reticulum: Continuing the Search for Genes Associated with Malignant Hyperthermia

  2016cites this paper
• Cystathionine β-synthase-derived hydrogen sulfide is involved in human malignant hyperthermia.

  2016cites this paper
• The Journal of Macro Trends in Health and Medicine A Strategy for DNA Sequencing of CASQ 1 reveals no mutations associated with malignant hyperthermia

  2016cites this paper
• Telefonische Anfragen zum Thema maligne Hyperthermie

  2015cites this paper
• Impact of New Genomic Technologies on Understanding Adverse Drug Reactions

  2015cites this paper
• Babies in Distress

  2015cites this paper
• Essential Role of Calmodulin in RyR Inhibition by Dantrolene

  2015influential citation
• Malignant Hyperthermia: An Inherited Disorder of Muscle Calcium Metabolism

  2015cites this paper
• European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility.

  2015cites this paper
• Malignant Hyperthermia: An Update

  2015cites this paper
• Neuromuscular conditions associated with malignant hyperthermia in paediatric patients: A 25-year retrospective study.

  2015cites this paper
• Management of malignant hyperthermia: diagnosis and treatment

  2014cites this paper
• Ryanodine Receptor 1 and Associated Pathologies

  2014cites this paper
• Calcium Homeostasis in Myogenic Differentiation Factor 1 (MyoD)-Transformed, Virally-Transduced, Skin-Derived Equine Myotubes

  2014cites this paper
• Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study

  2014cites this paper
• Should computer-based medical education be a solution for treatment of rarely seen diseases? A forensic death case due to malignant hyperthermia

  2014cites this paper
• Congenital (Structural) Myopathies

  2014cites this paper
• Malignant hyperthermia testing in probands with NO adverse anesthetic reaction

  2014cites this paper
• DNA Testing for Malignant Hyperthermia: The Reality and the Dream

  2014cites this paper
• Mutation discovery for Mendelian traits in non-laboratory animals: a review of achievements up to 2012

  2013cites this paper
• Hereditary Muscle Channelopathies

  2013cites this paper
• Genome-Wide Linkage Analysis of Cardiovascular Disease Biomarkers in a Large, Multigenerational Family

  2013cites this paper
• Core myopathies and malignant hyperthermia susceptibility: a review

  2013cites this paper
• Maligne Hyperthermie (MH)

  2012cites this paper
• Chapter 9 – Muscle Diseases

  2012cites this paper
• Neue Telefonnummer für die deutschlandweite "Rund-um-die-Uhr"- Anlaufstelle: 08221/9600

  2011cites this paper
• Malignant Hyperthermia and Central Core Disease

  2011cites this paper
• Novel missense mutations and unexpected multiple changes of RYR1 gene in 75 malignant hyperthermia families

  2011cites this paper
• MEDICAL MANAGEMENT AND PHARMACOLOGY UPDATE

  2011cites this paper
• Hotline für maligne Hyperthermie

  2011cites this paper
• Clinical utility gene card for: malignant hyperthermia

  2011cites this paper
• Mechanistic models for muscle diseases and disorders originating in the sarcoplasmic reticulum.

  2011cites this paper
• Malignant hyperthermia in the oral and maxillofacial surgery patient: an update.

  2011cites this paper
• Malignant hyperthermia in India

  2010cites this paper
• Functional Studies of RYR1 Mutations in the Skeletal Muscle Ryanodine Receptor Using Human RYR1 Complementary DNA

  2010cites this paper
• Identification and functional characterization of malignant hyperthermia mutation T1354S in the outer pore of the Cavalpha1S-subunit.

  2010cites this paper
• Allele-specific differences in ryanodine receptor 1 mRNA expression levels may contribute to phenotypic variability in malignant hyperthermia

  2010cites this paper
• Store-operated Ca2+ Entry in Malignant Hyperthermia-susceptible Human Skeletal Muscle*

  2010cites this paper
• Delayed malignant hyperthermia after routine coronary artery bypass.

  2010cites this paper
• Morphological diagnosis of hyperthermia-related deaths

  2010cites this paper
• SEQUENCE VARIANTS IN THE RYR1 GENE AND GENETIC DISEASES: MALIGNANT HYPERTHERMIA AND CONGENITAL MYOPATHIES

  2009cites this paper
• The role of CACNA1S in predisposition to malignant hyperthermia

  2009cites this paper
• Localization of the calcium release channel gene in cattle and horse by in situ hybridization: evidence of a conserved synteny with glucose phosphate isomerase.

  2009cites this paper
• DNA sequence of the skeletal muscle calcium release channel cDNA and verification of the Arg615----Cys615 mutation, associated with porcine malignant hyperthermia, in Norwegian landrace pigs.

  2009cites this paper
• A rapid detection method for the ryanodine receptor 1 (C7360G) mutation in Quarter Horses.

  2009cites this paper
• Malignant hyperthermia associated with ryanodine receptor 1 (C7360G) mutation in Quarter Horses.

  2009cites this paper
• Sheep linkage mapping: restriction fragment length polymorphism detection with heterologous cDNA probes.

  2009cites this paper
• Calcium-induced calcium release in skeletal muscle.

  2009cites this paper
• Scientific advances in the genetic understanding and diagnosis of malignant hyperthermia.

  2009cites this paper
• Nutrigenomics Approach-A Strategy for Identification of Nutrition Responsive Genes Influencing Meat Edible Quality Traits in Swine

  2009cites this paper
• Complications of Pediatric Head and Neck Surgery

  2009cites this paper
• Multiple restriction fragment length polymorphisms in the porcine calcium release channel gene (CRC): assignment to the halothane (HAL) linkage group.

  2009cites this paper
• Organization and evolution of mitochondrial gene clusters in human.

  2008cites this paper
• Anestesia en la hipertemia maligna

  2008cites this paper
• A Double Mutation of the Ryanodine Receptor Type 1 Gene in a Malignant Hyperthermia Family with Multiminicore Myopathy

  2008cites this paper
• Non-immobilizing inhalational anesthetic-like compounds.

  2008cites this paper
• DNA Analysis and Malignant Hyperthermia Susceptibility

  2008cites this paper
• Los trastornos del movimiento en urgencias Movement disorders in the emergency department

  2008cites this paper
• Identification of Genetic Mutations in Australian Malignant Hyperthermia Families Using Sequencing of Ryr1 Hotspots

  2008cites this paper
• Malignant hyperthermia: a pharmacogenetic disorder.

  2008cites this paper
• Malignant hyperthermia and associated conditions.

  2007cites this paper
• Undetected central core disease myopathy in an infant presenting for clubfoot surgery

  2007cites this paper
• Злокачественная гипертермия Malignant hyperthermia

  2007cites this paper
• Medical genetics--genes and GPs for the 1990s.

  2007cites this paper
• Genetics of Malignant Hyperthermia

  2006cites this paper
• Malignant Hyperthermia and Central Core Disease

  2006cites this paper
• Mutations in RYR1 in malignant hyperthermia and central core disease

  2006cites this paper
• Functional effects of mutations in the skeletal muscle ryanodine receptor type 1 (RYR1) linked to malignant hyperthermia and central core disease

  2006cites this paper
• Anestesia y miopatías

  2006cites this paper
• Anesthésie et myopathies

  2006cites this paper
• Molecular genetics of behaviour: research strategies and perspectives for animal production

  2005influential citation
• Intracellular Ca2+ dynamics in malignant hyperthermia and central core disease: established concepts, new cellular mechanisms involved.

  2005cites this paper
• Malignant hyperthermia: update on susceptibility testing.

  2005cites this paper
• Muscle channelopathies and critical points in functional and genetic studies.

  2005cites this paper
• Denaturing High Performance Liquid Chromatography Screening of Ryanodine Receptor Type 1 Gene in Patients with Malignant Hyperthermia in Taiwan and Identification of a Novel Mutation (Y522C)

  2005cites this paper